Skip to search formSkip to main contentSkip to account menu

brofaromine

Known as: 4-(5-methoxy-7-bromobenzofuranyl)-2-piperidine, Piperidine, 4-(7-bromo-5-methoxy-2-benzofuranyl)-, hydrochloride, brofaromin 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

CGP 11305Abrofaromine hydrochloride

Broader (2)

Monoamine Oxidase InhibitorsPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies.
1997
1997
Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain.
1996
1996
A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
Previous studies have shown that both selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs… 
Highly Cited
1995
Highly Cited
1995
A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic… 
Highly Cited
1994
Highly Cited
1994
Effect of l-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake
Highly Cited
1993
Highly Cited
1993
The sleep eeg and nocturnal hormonal secretion studies on changes during the course of depression and on effects of cns-active drugs
Review
1992
Review
1992
The new generation of monoamine oxidase inhibitors.
Irreversible and unspecific inhibitors of MAO were the first modern antidepressants, but after an initial success they fell into… 
1989
1989
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
Brofaromine (CGP 11 305 A), a new reversible and selective MAO-A inhibitor, was studied in two multicentre, (Trial A and Trial B… 
Highly Cited
1989
Highly Cited
1989
Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors.
Healthy ambulatory subjects were treated p.o. for 2 to 4 weeks with 6 different MAO inhibitors (MAOI). MAOI drugs were given to… 
Highly Cited
1988
Highly Cited
1988
Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects.
The pressor effect of orally administered tyramine (TYR) has been evaluated in 124 tests of 49 healthy unmedicated volunteers, in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)